Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M101350200 on July 5, 2001

J. Biol. Chem., Vol. 276, Issue 35, 32506-32514, August 31, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/35/32506    most recent
M101350200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogretmen, B.
Right arrow Articles by Obeid, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogretmen, B.
Right arrow Articles by Obeid, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition in the A549 Human Lung Adenocarcinoma Cell Line*

Besim OgretmenDagger §, Jacqueline M. Kraveka, Deborah SchadyDagger , Julnar Usta||, Yusuf A. HannunDagger , and Lina M. Obeid**

From the Dagger  Departments of Biochemistry and Molecular Biology and  Pediatrics, Division of Hematology/Oncology, and ** Medicine and Ralph H. Johnson Veteran Administration, Medical University of South Carolina, Charleston, South Carolina 29425, and the || Department of Biochemistry, American University of Beirut, Beirut, Lebanon

This study was aimed at identifying the molecular mechanisms by which ceramide inhibits telomerase activity in the A549 human lung adenocarcinoma cell line. C6-ceramide (20 µM) caused a significant reduction of telomerase activity at 24 h as detected using the telomeric repeat amplification protocol, and this inhibition correlated with decreased telomerase reverse transcriptase (hTERT) protein. Semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and Northern blot analyses showed that C6-ceramide significantly decreased hTERT mRNA in a time-dependent manner. Electrophoretic mobility shift and supershift assays demonstrated that the binding activity of c-Myc transcription factor to the E-box sequence on the hTERT promoter was inhibited in response to C6-ceramide at 24 h. These results were also confirmed by transient transfections of A549 cells with pGL3-Basic plasmid constructs containing the functional hTERT promoter and its E-box deleted sequences cloned upstream of a luciferase reporter gene. Further analysis using RT-PCR and Western blotting showed that c-Myc protein but not its mRNA levels were decreased in response to C6-ceramide at 24 h. The effects of ceramide on the c-Myc protein were shown to be due to a reduction in half-life via increased ubiquitination. Similar results were obtained by increased endogenous ceramide levels in response to nontoxic concentrations of daunorubicin, resulting in the inhibition of telomerase and c-Myc activities. Furthermore, the elevation of endogenous ceramide by overexpression of bacterial sphingomyelinase after transient transfections also induced the inhibition of telomerase activity with concomitant decreased hTERT and c-Myc protein levels. Taken together, these results show for the first time that both exogenous and endogenous ceramides mediate the modulation of telomerase activity via decreased hTERT promoter activity caused by rapid proteolysis of the ubiquitin-conjugated c-Myc transcription factor.


* This work was supported in part by research grants from the Department of Energy through the Environmental Biosciences Program at MUSC, American Cancer Society Grant IRG-97-151-01, and Department of Defense, Coastal Carolina Program Project project number 2 at Hollings Cancer Center (to B. O.), and National Institutes of Health Grants CA87584 and GM43825 (to Y. A. H.) and AG16583 and AG12467 (to L. M. O.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Medical University of South Carolina, Dept. of Biochemistry and Molecular Biology, P. O. Box 250779, Charleston, SC 29425. Tel.: 843-876-5192; Fax: 843-876-5172; E-mail: ogretmen@musc.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
A. Mukhopadhyay, S. A. Saddoughi, P. Song, I. Sultan, S. Ponnusamy, C. E. Senkal, C. F. Snook, H. K. Arnold, R. C. Sears, Y. A. Hannun, et al.
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
FASEB J, March 1, 2009; 23(3): 751 - 763.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
L. G. Wooten-Blanks, P. Song, C. E. Senkal, and B. Ogretmen
Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1
FASEB J, October 1, 2007; 21(12): 3386 - 3397.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Senkal, S. Ponnusamy, M. J. Rossi, K. Sundararaj, Z. Szulc, J. Bielawski, A. Bielawska, M. Meyer, B. Cobanoglu, S. Koybasi, et al.
Potent Antitumor Activity of a Novel Cationic Pyridinium-Ceramide Alone or in Combination with Gemcitabine against Human Head and Neck Squamous Cell Carcinomas in Vitro and in Vivo
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1188 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Li, N. Idamakanti, T. Arroyo, S. Thorne, T. Reid, S. Nichols, M. VanRoey, G. Colbern, N. Nguyen, O. Tam, et al.
Dual Promoter-Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
Clin. Cancer Res., December 15, 2005; 11(24): 8845 - 8855.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Rouquette-Jazdanian, A. Foussat, L. Lamy, C. Pelassy, P. Lagadec, J.-P. Breittmayer, and C. Aussel
Cholera Toxin B-Subunit Prevents Activation and Proliferation of Human CD4+ T Cells by Activation of a Neutral Sphingomyelinase in Lipid Rafts
J. Immunol., November 1, 2005; 175(9): 5637 - 5648.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Beyne-Rauzy, N. Prade-Houdellier, C. Demur, C. Recher, J. Ayel, G. Laurent, and V. Mansat-De Mas
Tumor necrosis factor-{alpha} inhibits hTERT gene expression in human myeloid normal and leukemic cells
Blood, November 1, 2005; 106(9): 3200 - 3205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. G. Wooten and B. Ogretmen
Sp1/Sp3-dependent Regulation of Human Telomerase Reverse Transcriptase Promoter Activity by the Bioactive Sphingolipid Ceramide
J. Biol. Chem., August 12, 2005; 280(32): 28867 - 28876.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Kurinna, C. C. Tsao, A. F. Nica, T. Jiffar, and P. P. Ruvolo
Ceramide Promotes Apoptosis in Lung Cancer-Derived A549 Cells by a Mechanism Involving c-Jun NH2-Terminal Kinase
Cancer Res., November 1, 2004; 64(21): 7852 - 7856.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Koybasi, C. E. Senkal, K. Sundararaj, S. Spassieva, J. Bielawski, W. Osta, T. A. Day, J. C. Jiang, S. M. Jazwinski, Y. A. Hannun, et al.
Defects in Cell Growth Regulation by C18:0-Ceramide and Longevity Assurance Gene 1 in Human Head and Neck Squamous Cell Carcinomas
J. Biol. Chem., October 22, 2004; 279(43): 44311 - 44319.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Marchesini, W. Osta, J. Bielawski, C. Luberto, L. M. Obeid, and Y. A. Hannun
Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells
J. Biol. Chem., June 11, 2004; 279(24): 25101 - 25111.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Symolon, E. M. Schmelz, D. L. Dillehay, and A. H. Merrill Jr.
Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and ApcMin/+ Mice
J. Nutr., May 1, 2004; 134(5): 1157 - 1161.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. P. Sundararaj, R. E. Wood, S. Ponnusamy, A. M. Salas, Z. Szulc, A. Bielawska, L. M. Obeid, Y. A. Hannun, and B. Ogretmen
Rapid Shortening of Telomere Length in Response to Ceramide Involves the Inhibition of Telomere Binding Activity of Nuclear Glyceraldehyde-3-phosphate Dehydrogenase
J. Biol. Chem., February 13, 2004; 279(7): 6152 - 6162.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
L. M. Obeid and Y. A. Hannun
Ceramide, Stress, and a "LAG" in Aging
Sci. Aging Knowl. Environ., October 1, 2003; 2003(39): pe27 - 27.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
I. Horikawa and J. C. Barrett
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms
Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-J. Kroesen, S. Jacobs, B. J. Pettus, H. Sietsma, J. W. Kok, Y. A. Hannun, and L. F. M. H. de Leij
BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome
J. Biol. Chem., April 18, 2003; 278(17): 14723 - 14731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. W. Elmore, C. W. Rehder, X. Di, P. A. McChesney, C. K. Jackson-Cook, D. A. Gewirtz, and S. E. Holt
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
J. Biol. Chem., September 13, 2002; 277(38): 35509 - 35515.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
Q. Wang, H. Liu, and P. J. Szaniszlo
Compensatory expression of five chitin synthase genes, a response to stress stimuli, in Wangiella (Exophiala) dermatitidis, a melanized fungal pathogen of humans
Microbiology, September 1, 2002; 148(9): 2811 - 2817.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. A. Hannun and L. M. Obeid
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
J. Biol. Chem., July 12, 2002; 277(29): 25847 - 25850.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson
Natural and pharmacological regulation of telomerase
Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement